Technology Bundle ID: TAB-772

Methods and Materials for Controlling Stem Cell and Cancer Cell Proliferation and Differentiation

Request More Info
Primary Inventors: 
Robert Tsai (NINDS)
Co-Inventors: 
Ronald McKay (NINDS)
Application: 
Therapeutics
Institute or Center: 
NINDS

This work describes a novel nucleolar mechanism that controls the cell-cycle progression in CNS stem cells and cancer cells. The inventors identified a novel peptide, nucleostemin, found in the nucleoli of CNS stem cells, embryonic stem cells, and several cancer cell lines and preferentially expressed by other stem cell-enriched populations. When stem cells differentiate, nucleostemin expression decreases rapidly prior to cell-cycle exit both in vitro and in vivo. Depletion or overexpression of nucleostemin reduces cell proliferation in CNS stem cells and transformed cells.

Nucleic acids encoding the polypeptide, vectors incorporating the nucleic acids, and host cells transfected with these nucleic acids are disclosed and claimed. The claimed invention includes methods for regulating cell differentiation, cell proliferation, or both using nucleostemin. Methods for inducing differentiation, inhibiting proliferation, and inducing senescence of a cell by altering the level of a nucleostemin polypeptide and related amino acid sequences are disclosed and claimed. Methods for screening for agents that affect proliferation, differentiation, or senescence of cells are also disclosed and claimed. Further information can be found in Genes Dev. 2002 Dec 1;16 (23):2991-3003.

Patents

EIR Application
PCT Application PCT/US03/31321
Filed on 2003-10-01
US Application 10/530,340
Filed on 2005-04-01
US Application 60/415,867
Filed on 2002-10-02
US Application 60/442,005
Filed on 2003-01-22

Updated

Oct 1, 2003

Data Source: 
tts